期刊文献+

CyclinD、P16在子宫内膜异位症中的表达及意义 被引量:3

Expression of CyclinD and P16 in Endometriosis
在线阅读 下载PDF
导出
摘要 采用免疫组化法检测子宫内膜异位症(EMs)及对照组子宫内膜CyclinD和P16的表达。发现EMs组异位和在位内膜中两者的表达无显著差异(P〉O.05),EMs组CyclinD的表达均高于对照组,而P16低于对照组,CyclinD在EMsⅠ期~Ⅱ期的表达低于Ⅲ期~Ⅳ期,P16的表达高于Ⅲ期~Ⅳ期,两者呈负相关,对照组与在位内膜CyclinD表达分泌期低于增生期,P16高于增生期(P均〈0.05),而异位内膜的表达无周期性改变(P〉0.05),提示两者在EMs的发生发展中起重要作用。 Immunohistochemical methods were used to examine the expression of CyclinD and P16 of endometriosis(EMs) and control group. We found that the expression of the CyclinD and P16 had no significant difference between ectopic endometrium and eutopic endometrium of EMs(P〉0.05), but CyclinD were higher than that of the control, while P16 were lower than that of the control. The expression of CyclinD in endometriosis stage Ⅰ--Ⅱ was significant lower than the stage Ⅲ--Ⅳ. The expression of P16 in stage Ⅰ--Ⅱ of endometriosis was significant higher than the stage Ⅲ--Ⅳ. There was a negative spearman correlation between the expression of CyclinD and P16 in ectopic group. The CyclinD expression of the normal endometriosis and eutopic endometrium in the proliferative phase were more than that in the secretory phase. The P16 expression of the normal endometriosis and eutopic endometrium in the proliferative phase were lower than that in the secretory phase(all P〈0.05). Ectopic endometrium showed no cyclic change(P〉0.05), That means that both of them may play an important role of the pathogenesis and the progress of EMs.
出处 《医学与哲学(B)》 2008年第7期41-42,45,共3页 Medicine & Philosophy(B)
关键词 CYCLIND P16 基因 子宫内膜异位症 CyclinD P16 gene endometriosis
  • 相关文献

参考文献3

二级参考文献11

  • 1Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest, 1998, 78:269-276.
  • 2Ajchenbaum F, Ando K, DeCaprio JA, et al. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem, 1993, 268:4113-4119.
  • 3Tsubari M, Tiihonen E, Laiho M. Cloning and characterization of p16, an alternatively spliced form of p15 cyclin-dependent kinase inhibitor. Cancer Res, 1997,57:2966-2973.
  • 4David LO.Endometriosis in clinical practice.New York:Taylore Frances Group,2005.193-200.
  • 5Tulandi T,Redwine D.Endometriosis.Advances and controversies.New York:Marce Dekker,2004.210-216.
  • 6Redwine D.Surgical management of endometriosis.New York:Taylore Frances Group,2004.149-157.
  • 7辛晓燕,王健,王德堂,刘淑娟,严瑞兰,郑维国.卵巢上皮性肿瘤CyclinD_1及pRb的表达与其良恶性关系[J].第四军医大学学报,2000,21(3):343-346. 被引量:5
  • 8冯凯,吕晓霞.大肠癌患者检测P^(16)和Cyclin D_1的临床意义[J].山东医药,2000,40(13):5-7. 被引量:2
  • 9吴玉新,王靖华,步宏.细胞周期素D1与肿瘤研究[J].诊断病理学杂志,2000,7(3):219-221. 被引量:6
  • 10郎景和.子宫内膜异位症基础与临床研究的几个问题[J].中国实用妇科与产科杂志,2002,18(3):129-130. 被引量:301

共引文献101

同被引文献18

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部